Maternus-Kliniken Aktiengesellschaft (FRA:MAK)

FRA:MAK Statistics

Total Valuation

FRA:MAK has a market cap or net worth of EUR 27.47 million. The enterprise value is 133.20 million.

Market Cap	27.47M
Enterprise Value	133.20M

Important Dates

The next estimated earnings date is Monday, September 8, 2025.

Earnings Date	Sep 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.97M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	-2.33%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.24
PB Ratio	-0.42
P/TBV Ratio	n/a
P/FCF Ratio	1.98
P/OCF Ratio	1.82
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.55, with an EV/FCF ratio of 9.61.

EV / Earnings	-10.12
EV / Sales	1.17
EV / EBITDA	15.55
EV / EBIT	n/a
EV / FCF	9.61

Financial Position

The company has a current ratio of 0.13

Current Ratio	0.13
Quick Ratio	0.09
Debt / Equity	n/a
Debt / EBITDA	12.54
Debt / FCF	7.75
Interest Coverage	-0.47

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1.69%
Return on Invested Capital (ROIC)	-4.87%
Return on Capital Employed (ROCE)	-56.52%
Revenue Per Employee	78,515
Profits Per Employee	-9,061
Employee Count	1,452
Asset Turnover	0.77
Inventory Turnover	184.45

Taxes

In the past 12 months, FRA:MAK has paid 2.88 million in taxes.

Income Tax	2.88M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-33.15%
50-Day Moving Average	1.33
200-Day Moving Average	1.45
Relative Strength Index (RSI)	59.31
Average Volume (20 Days)	589

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:MAK had revenue of EUR 114.00 million and -13.16 million in losses. Loss per share was -0.63.

Revenue	114.00M
Gross Profit	22.33M
Operating Income	-3.99M
Pretax Income	-10.33M
Net Income	-13.16M
EBITDA	-773,000
EBIT	-3.99M
Loss Per Share	-0.63

Balance Sheet

The company has 3.29 million in cash and 107.44 million in debt, giving a net cash position of -104.15 million.

Cash & Cash Equivalents	3.29M
Total Debt	107.44M
Net Cash	-104.15M
Net Cash Per Share	n/a
Equity (Book Value)	-65.25M
Book Value Per Share	-3.19
Working Capital	-115.80M

Cash Flow

In the last 12 months, operating cash flow was 15.07 million and capital expenditures -1.22 million, giving a free cash flow of 13.86 million.

Operating Cash Flow	15.07M
Capital Expenditures	-1.22M
Free Cash Flow	13.86M
FCF Per Share	n/a

Margins

Gross margin is 19.59%, with operating and profit margins of -3.50% and -11.54%.

Gross Margin	19.59%
Operating Margin	-3.50%
Pretax Margin	-9.06%
Profit Margin	-11.54%
EBITDA Margin	-0.68%
EBIT Margin	-3.50%
FCF Margin	12.15%

Dividends & Yields

FRA:MAK does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-47.89%
FCF Yield	50.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 1, 1996. It was a forward split with a ratio of 20.

Last Split Date	Oct 1, 1996
Split Type	Forward
Split Ratio	20

Scores

FRA:MAK has an Altman Z-Score of -1.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.38
Piotroski F-Score	2